Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

436 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial.
Monk BJ, Poveda A, Vergote I, Raspagliesi F, Fujiwara K, Bae DS, Oaknin A, Ray-Coquard I, Provencher DM, Karlan BY, Lhommé C, Richardson G, Rincón DG, Coleman RL, Herzog TJ, Marth C, Brize A, Fabbro M, Redondo A, Bamias A, Tassoudji M, Navale L, Warner DJ, Oza AM. Monk BJ, et al. Among authors: raspagliesi f. Lancet Oncol. 2014 Jul;15(8):799-808. doi: 10.1016/S1470-2045(14)70244-X. Epub 2014 Jun 17. Lancet Oncol. 2014. PMID: 24950985 Clinical Trial.
Management of peritoneal surface component of ovarian cancer.
Deraco M, Raspagliesi F, Kusamura S. Deraco M, et al. Among authors: raspagliesi f. Surg Oncol Clin N Am. 2003 Jul;12(3):561-83. doi: 10.1016/s1055-3207(03)00027-9. Surg Oncol Clin N Am. 2003. PMID: 14567018 Review.
Paclitaxel 175 or 225 mg per meters squared with carboplatin in advanced ovarian cancer: a randomized trial.
Bolis G, Scarfone G, Polverino G, Raspagliesi F, Tateo S, Richiardi G, Melpignano M, Franchi M, Mangili G, Presti M, Villa A, Conta E, Guarnerio P, Cipriani S, Parazzini F. Bolis G, et al. Among authors: raspagliesi f. J Clin Oncol. 2004 Feb 15;22(4):686-90. doi: 10.1200/JCO.2004.03.017. J Clin Oncol. 2004. PMID: 14966092 Free article. Clinical Trial.
Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan.
Raspagliesi F, Kusamura S, Campos Torres JC, de Souza GA, Ditto A, Zanaboni F, Younan R, Baratti D, Mariani L, Laterza B, Deraco M. Raspagliesi F, et al. Eur J Surg Oncol. 2006 Aug;32(6):671-5. doi: 10.1016/j.ejso.2006.03.011. Epub 2006 Apr 18. Eur J Surg Oncol. 2006. PMID: 16621425
The role of secondary surgery in recurrent ovarian cancer.
Lorusso D, Mancini M, Di Rocco R, Fontanelli R, Raspagliesi F. Lorusso D, et al. Among authors: raspagliesi f. Int J Surg Oncol. 2012;2012:613980. doi: 10.1155/2012/613980. Epub 2012 Aug 5. Int J Surg Oncol. 2012. PMID: 22919475 Free PMC article.
436 results